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Translating molecular bioscience and experimental research into medical insights, Clinical Science 
(published by Portland Press, the wholly-owned subsidiary of the Biochemical Society) has been 
offering multi-disciplinary coverage and clinical perspectives for nearly 50 years.  
What we publish 
The Journal publishes original papers and review articles of high scientific merit, covering the broad 
spectrum of biomedical specialities. The Journal publishes key findings in the fields of cardiovascular 
system, cerebrovascular system, gastrointestinal tract and liver, genetics and functional genomics, 
infection and immunity, inflammation and oncology, metabolism, endocrinology and nutrition, 
nephrology and circulation, respiratory system, and vascular biology. Testament to the quality, the 
Journal is ranked 16 out of 124 (within the top quartile) of journals in the Medicine (Research and 
Experimental) category of the 2015 Journal Citation Reports (Thomson Reuters). 
Owing to the name “Clinical Science”, we are sometimes mistaken for a medical journal that 
publishes Phase II/III clinical trials. However, the content published in Clinical Science is decidedly in 
the area of molecular mechanisms and pathways that explain, illustrate, and indeed underpin 
health/disease. In publishing such work, the aim of the Journal is to surface therapeutic targets of 
possible potential, to provide meaningful insight into future medical strategies and to inspire 
pharmacological innovation.   
Global experts to shepherd unique and insightful content 
We are very proud of the expertise that we have on the Editorial Board, and in 2016 we recruited 
new Associate Editors, complementing our existing Editorial Board. Professor Hongliang Li, based at 
the Medical Research Institute in Wuhan (China) specialises in the innate immunity network in 
cardiometabolic disorders, and also the cerebrovascular system. Professor Ilja Striz is Head of the 
Department of Clinical and Transplant Immunology at the Institute for Clinical and Experimental 
Medicine (IK+EM) in Prague (Czech Republic) and has expertise in immunity and inflammation. 
Finally, Associate Professor Ross Vlahos, based at the School of Health and Biomedical Sciences at 
RMIT University, Melbourne (Australia) is interested in the respiratory system, in particular asthma, 
chronic obstructive pulmonary disease, and lung inflammation.    
2016 saw the publication of a series of papers on gender and molecular medicine, including 
commissioned review articles and key research. The themed collection, guest edited by Professor 
Jane Reckelhoff (University of Mississippi Medical Center, and current President of the American 
Physiological Society), includes papers by key researchers in the field, including members of the 
Board of the International Society for Gender Medicine, Giovannella Baggio, Marianne J. Legato, 
Virginia M. Miller and Vera Regitz-Zagrosek. We are looking forward in 2017 to producing a similar 
themed collection on small vessels, dementia and chronic diseases. This was initiated by the 
Vascular Experimental Theme of the Dementias Platform UK, and complements a workshop that was 
held in January 2017 bringing together key players in dementia and stroke research. The themed 
collection will be guest edited by Professor Joanna Wardlaw (Chair of Applied Neuroimaging and 
Head of Neuroimaging Sciences, University of Edinburgh). An editorial introducing the collection is 
already available at http://www.clinsci.org/content/130/21/1875. 
Commissioned review articles in the journal highlight key areas of research, and Professor Mark 
Cooper (Head of the Department of Diabetes, Central Clinical School, Monash University, Australia) 
overseas the process as Reviews Editor. Our review articles are often specifically invited papers from 
experts around the world and the articles and topics are selected to be unique and insightful 
advances on existing knowledge. Review papers from 2016 that show the breadth of Clinical Science 
coverage include: 
 Molecular mechanisms for vascular complications of targeted cancer therapies (Srila Gopal, 
Kenneth B. Miller, Iris Z. Jaffe) 
 Energy balance, body composition, sedentariness and appetite regulation: pathways to 
obesity (Mark Hopkins, John E. Blundell) 
 Protein kinase C mechanisms that contribute to cardiac remodelling (Alexandra C. Newton, 
Corina E. Antal, Susan F. Steinberg) 
 Mitochondrial health, the epigenome and healthspan (Miguel A. Aon, Sonia Cortassa, 
Magdalena Juhaszova, Steven J. Sollott) 
 Neurotrophin signalling: novel insights into mechanisms and pathophysiology (Mariela 
Mitre, Abigail Mariga, Moses V. Chao) 
 
Image Library 
I am particularly proud of the Clinical Science Image Library. The library is a collection of figures from 
selected papers published in the journal, all of which are curated by keyword. The figure is provided 
along with the figure caption and a link to the abstract of the original paper. Each month, one of the 
Clinical Science Associate Editors chooses an image of the month that is promoted by the Journal 
and Portland Press and this receives a good amount of interest via Twitter. Whether seeking a 
diagram for explaining the mechanism of action for everolimus [1] or seeking a pathway depiction of 
the NADPH-oxidase regulated inflammatory response [2], a rich variety of images are available via 
the journal’s Image Library. 
Your translational research 
Why not join your colleagues and peers in submitting your work to the Journal for consideration? 
We welcome all research with a translational aspect to the work, and we encourage you to submit 
research that links basic science to disease mechanisms to clinsci.msubmit.net. Equally, if you have a 
pre-submission query, please send this to editorial@portlandpress.com.  
Papers published in Clinical Science emphasise the translational nature of science and any articles 
submitted need to ensure that the basic science research being reported translates into benefits for 
human health and disease. To speak to this, all papers published in the Journal carry a ‘Clinical 
Perspectives’ section. This section helps to focus the authors and the readers to the translational 
aspect of the work, covering the following three bullet points: (i) background as to why the study 
was undertaken, (ii) a brief summary of the results, and (iii) the potential significance of the results 
to human health and disease. 
All submitted articles that are deemed suitable for formal consideration by the Editorial Board will 
receive full and fair peer review. In most cases, a first decision is returned to submitting authors 
within 30 days. We look forward to working with you on the consideration and possible publication 
of your next article in Clinical Science.  
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